AusPAR: Forxiga

Australian Public Assessment Report

AusPAR

AusPAR: Dapagliflozin (as propanediol monohydrate) [PDF, 696.66 KB]

AusPAR: Dapagliflozin (as propanediol monohydrate) [Word, 2.48 MB]

Attachment: Product information for Dapagliflozin (as propanediol monohydrate) [PDF, 1.19 MB]

Attachment: Product information for Dapagliflozin (as propanediol monohydrate) [Word, 1.52 MB]

Device/Product Name

Forxiga

Active ingredients

Dapagliflozin (as propanediol monohydrate)

AusPAR Date

28 March 2022

Published

11 April 2022

Submission Number

PM-2020-06068-1-5

Submission Type

Extension of indications

Decision

Approved